Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system.

2.50
Hdl Handle:
http://hdl.handle.net/10541/108874
Title:
Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system.
Authors:
Madej, Monika; Conway, Margaret J; Morgan, A J; Sweet, J; Wallace, L; Qualtiere, L F; Arrand, John R; Mackett, Mike
Abstract:
Our initial results with a bovine papilloma virus (BPV) vector expression system indicated that we could produce significant amounts of Epstein-Barr virus (EBV) gp340/220 in the supernatant of a mouse fibroblast cell line. We have now extended these findings to show that the truncated version of gp340/220, where the membrane anchor sequence is deleted, is produced even after extended passage of the cells, at a level of approximately 1 mg/4 x 10(8) cells. A simple purification protocol using Sephacryl S300HR and gelatin agarose gives a product which is greater than 90% pure. This product is recognized by anti-gp340 monoclonal antibodies from five different epitope groups and induces antibody that recognizes the authentic gp340/220 and neutralizes EBV in vitro. The purified gp340/220 can be used in ELISA and stimulates the proliferation of T-cell clones specific for gp340/220. These characteristics, together with the fact that BPV-transformed lines have been utilized for the production of pharmaceuticals for use in humans, suggest that this gp340/220 is suitable as a source of antigen for vaccination to prevent EBV infection and related diseases.
Affiliation:
Department of Molecular Biology, Paterson Institute for Cancer Research, Manchester, UK.
Citation:
Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system. 1992, 10 (11):777-82 Vaccine
Journal:
Vaccine
Issue Date:
1992
URI:
http://hdl.handle.net/10541/108874
DOI:
10.1016/0264-410X(92)90513-J
PubMed ID:
1332270
Type:
Article
Language:
en
ISSN:
0264-410X
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorMadej, Monikaen
dc.contributor.authorConway, Margaret Jen
dc.contributor.authorMorgan, A Jen
dc.contributor.authorSweet, Jen
dc.contributor.authorWallace, Len
dc.contributor.authorQualtiere, L Fen
dc.contributor.authorArrand, John Ren
dc.contributor.authorMackett, Mikeen
dc.date.accessioned2010-08-03T08:18:34Z-
dc.date.available2010-08-03T08:18:34Z-
dc.date.issued1992-
dc.identifier.citationPurification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system. 1992, 10 (11):777-82 Vaccineen
dc.identifier.issn0264-410X-
dc.identifier.pmid1332270-
dc.identifier.doi10.1016/0264-410X(92)90513-J-
dc.identifier.urihttp://hdl.handle.net/10541/108874-
dc.description.abstractOur initial results with a bovine papilloma virus (BPV) vector expression system indicated that we could produce significant amounts of Epstein-Barr virus (EBV) gp340/220 in the supernatant of a mouse fibroblast cell line. We have now extended these findings to show that the truncated version of gp340/220, where the membrane anchor sequence is deleted, is produced even after extended passage of the cells, at a level of approximately 1 mg/4 x 10(8) cells. A simple purification protocol using Sephacryl S300HR and gelatin agarose gives a product which is greater than 90% pure. This product is recognized by anti-gp340 monoclonal antibodies from five different epitope groups and induces antibody that recognizes the authentic gp340/220 and neutralizes EBV in vitro. The purified gp340/220 can be used in ELISA and stimulates the proliferation of T-cell clones specific for gp340/220. These characteristics, together with the fact that BPV-transformed lines have been utilized for the production of pharmaceuticals for use in humans, suggest that this gp340/220 is suitable as a source of antigen for vaccination to prevent EBV infection and related diseases.en
dc.language.isoenen
dc.subject.meshAnimals-
dc.subject.meshAntibodies, Viral-
dc.subject.meshAntigens, Viral-
dc.subject.meshBovine papillomavirus 1-
dc.subject.meshClone Cells-
dc.subject.meshFibroblasts-
dc.subject.meshGene Expression Regulation-
dc.subject.meshGenetic Vectors-
dc.subject.meshLymphocyte Activation-
dc.subject.meshMembrane Proteins-
dc.subject.meshMice-
dc.subject.meshMice, Inbred BALB C-
dc.subject.meshT-Lymphocytes-
dc.subject.meshViral Envelope Proteins-
dc.subject.meshViral Matrix Proteins-
dc.titlePurification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system.en
dc.typeArticleen
dc.contributor.departmentDepartment of Molecular Biology, Paterson Institute for Cancer Research, Manchester, UK.en
dc.identifier.journalVaccineen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.